Jason B Harris Selected Research

cholera vaccine CVD 103-HgR

1/2021	Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine.
11/2018	Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
1/2018	Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason B Harris Research Topics

Disease

70	Cholera 12/2021 - 08/2005
48	Infections 08/2021 - 08/2005
9	Typhoid Fever (Typhoid) 01/2020 - 09/2006
9	Diarrhea 11/2019 - 10/2008
4	Bacteremia 07/2021 - 09/2006
3	Inflammation (Inflammations) 01/2022 - 11/2011
3	Dehydration (Water Stress) 01/2021 - 11/2009
2	COVID-19 03/2022 - 10/2020
2	Convalescence 01/2016 - 08/2015
1	Severe Acute Respiratory Syndrome 06/2022
1	Coronavirus Infections 03/2022
1	Pneumonia (Pneumonitis) 07/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Reinfection 01/2019
1	HIV Infections (HIV Infection) 09/2015
1	Paratyphoid Fever 03/2014
1	Fever (Fevers) 03/2014

Drug/Important Bio-Agent (IBA)

35	AntigensIBA 11/2021 - 09/2006
23	Cholera Vaccines FDA Link 11/2021 - 05/2009
22	Immunoglobulin G (IgG)IBA 03/2022 - 09/2006
22	Cholera ToxinIBA 12/2021 - 08/2005
21	VaccinesIBA 12/2021 - 08/2005
19	Immunoglobulin A (IgA)IBA 01/2021 - 04/2008
19	LipopolysaccharidesIBA 01/2021 - 04/2008
18	AntibodiesIBA 03/2022 - 04/2008
16	O Antigens (O Antigen)IBA 11/2021 - 11/2012
11	Immunoglobulin M (IgM)IBA 03/2022 - 01/2010
10	Proteins (Proteins, Gene)FDA Link 04/2019 - 09/2008
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2008
7	Polysaccharides (Glycans)IBA 01/2021 - 06/2013
6	Conjugate VaccinesIBA 11/2021 - 02/2014
6	Blood Group Antigens (Blood Groups)IBA 01/2021 - 11/2005
5	EnzymesIBA 01/2018 - 10/2008
4	CytokinesIBA 03/2015 - 08/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 11/2009
3	cholera vaccine CVD 103-HgRIBA 01/2021 - 01/2018
3	Monoclonal AntibodiesIBA 01/2021 - 12/2016
3	Indicators and Reagents (Reagents)IBA 10/2017 - 10/2005
3	shancholIBA 01/2016 - 05/2014
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021 - 02/2014
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2021
2	CarbohydratesIBA 01/2021 - 05/2015
2	Neuraminidase (Sialidase)IBA 01/2021 - 12/2016
2	Attenuated VaccinesIBA 11/2018 - 10/2018
2	InterferonsIBA 01/2018 - 06/2011
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 03/2015
2	MicronutrientsIBA 11/2016 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2011
2	ABO Blood-Group SystemIBA 01/2016 - 12/2011
2	ImmunosorbentsIBA 03/2014 - 10/2013
2	DukoralIBA 10/2013 - 05/2011
2	Bacterial Proteins (Bacterial Protein)IBA 05/2013 - 09/2006
2	Vitamin A (Retinol)FDA LinkGeneric 11/2008 - 04/2008
1	ChAdOx1 nCoV-19IBA 06/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 12/2021
1	AntitoxinsIBA 12/2021
1	Bacterial PolysaccharidesIBA 11/2021
1	Nucleic AcidsIBA 08/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2021
1	Ampicillin (Omnipen)FDA LinkGeneric 07/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2021
1	Capsules (Microcapsules)IBA 01/2021
1	colitoseIBA 01/2021
1	BuffersIBA 01/2021
1	IronIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	SARS-CoV-2 spike proteinIBA 10/2020
1	Neutralizing AntibodiesIBA 10/2020
1	CD40 Ligand (CD40L)IBA 04/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	Combined VaccinesIBA 10/2018
1	Dual OxidasesIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Bacterial VaccinesIBA 01/2017
1	Complementary DNA (cDNA)IBA 01/2016
1	LeptinIBA 08/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	Toll-Like Receptor 4IBA 03/2015
1	CaspasesIBA 03/2015
1	InflammasomesIBA 03/2015
1	Tetanus ToxinIBA 01/2015
1	magnololIBA 01/2015
1	honokiolIBA 01/2015
1	squaric acidIBA 01/2015
1	Interleukin-9 (Interleukin 9)IBA 06/2014
1	Interleukin-13IBA 06/2014
1	Interleukin-17 (Interleukin 17)IBA 06/2014
1	Hemolysin Proteins (Hemolysins)IBA 03/2014
1	4-O-carboxymethylascochlorinIBA 11/2012
1	Bovine Serum AlbuminIBA 11/2012
1	1-oleoyl-2-stearoylphosphatidylcholineIBA 11/2012

Therapy/Procedure

2	Therapeutics 05/2015 - 06/2012
1	Fluid Therapy (Oral Rehydration Therapy) 01/2018
1	Bathroom Equipment 08/2017